Market Business Insights - 28 December, 2022

As specified in our exclusive report, the Global Robotics Surgical Simulation Systems Market is projected to reach USD 1.71 billion by 2030.

Growth in this market is primarily driven by robotic-assisted surgery, technological advances in surgical robots, increasing adoption of surgical robots, and increased funding for medical robot research.

Impacting factor:

Globally, the demand for minimally invasive surgery (MIS) is increasing mainly because of the benefits associated with these procedures, such as fewer cuts, smaller incisions, less scarring, increased safety, reduced pain, faster recovery, and considerable cost savings. Robotic minimally invasive surgery combines these advantages by ensuring greater repeatability, accuracy, control, and efficiency.

Market Challenges:

Robot-assisted surgeries are more expensive than minimally invasive surgeries. The American Congress of Obstetricians and Gynecologists recommends robotic hysterectomy only for unusual and complex clinical conditions. The association says that the adoption of robotic surgery for all hysterectomies would add an estimated USD 962 million to the annual cost of hysterectomy surgery in the US. The da Vinci system, one of the most commonly used robotic systems, costs between USD 1.4 million and USD 2.4 million, while the CyberKnife robotic system costs around USD 4 million per unit.

Who is the Target Audience?

Surgical centers


Ambulatory surgical centers

Which Region Holds the Highest Share?

North America to hold the largest share over the forecast period. The high field growth is attributed to the increasing number of different surgical procedures with advanced technology. Additionally, major industry players are focusing on developing effective and precise surgical robots that will further accelerate the market expansion in North America.

Development of the Market:

January 2021: Stryker acquired OrthoSensor and its Verasense intraoperative sensor tech to strengthen the ortho giant’s Mako robots

January 2021: TransEnterix accepts CE Mark approval for its Intelligent Surgical Unit that adds AI-based capabilities and enables machine vision capabilities on TransEnterix’s Senhance robotic surgery system.

May 2022: Globus Medical announced Excelsius3D, an intelligent, intraoperative 3-in-1 imaging platform for surgeries with minimally invasive techniques. This will allow the firm to improve its surgical outcomes product portfolio.

Some of the key players in the robotics surgical simulation systems market are:

3D Systems Corporation, CAE Inc., Intuitive Surgical Inc., Mentice AB, Mimic Technologies, Inc., Simulated Surgical Systems, LLC, Touch of Life Technologies (ToLTech), VirtaMed AG, Voxel-Man, VRmagic., Auris Health Inc., CMR Surgical, Medtronic, Accuracy Incorporated, Maxar Technologies Limited.